Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 357.00
Bid: 357.00
Ask: 363.00
Change: -4.00 (-1.10%)
Spread: 6.00 (1.681%)
Open: 364.00
High: 369.00
Low: 357.00
Prev. Close: 364.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of RevStream

31 Aug 2017 07:00

RNS Number : 3757P
Microgen PLC
31 August 2017
 

microgen

www.microgen.com 31 August 2017

 

 

 

ACQUISITION OF REVSTREAM INC.

Microgen plc ('Microgen') is pleased to announce the acquisition of RevStream Inc. ('RevStream'), a California-based provider of revenue management enterprise software. The acquisition broadens and complements the specialist capabilities within Microgen's Aptitude Software business ('Aptitude') and provides access to RevStream's growing client base in the technology sector.

RevStream will be integrated into Aptitude which already has an established office in Boston and a strong North American presence with over 50% of H1 2017 Aptitude revenues generated in the US and Canada.

Since 2015 Aptitude has established a market leading position in the telecommunications sector with the Aptitude Revenue Recognition Engine ('ARRE'), an application which enables organisations to address the requirements of IFRS 15 and ASC 606. ARRE has established this strong position as a result of its capability to process very rapidly a very high volume of complex, business event-driven transactions and calculations. The acquisition of RevStream enables Aptitude to offer broader revenue management functionality which augments the specialised capabilities of ARRE.

RevStream's growing client base, primarily focussed on the technology sector, complements Aptitude's strong presence within the financial services, insurance and telecommunications sectors and provides cross-selling opportunities for both organisations' products. In addition, RevStream's existing cloud capabilities will be leveraged across Aptitude's new applications where cloud deployment is appropriate.

Consideration for the entire issued and to be issued shares of RevStream is £9.7 million. In addition, at completion RevStream had debt and debt-like items of £2.5 million which Microgen will settle under its ownership. Of the consideration of £9.7 million, £7.7 million is expected to be payable in cash of which approximately 70% was paid on completion with the remaining 30% payable across the following two-year period. The initial cash consideration was satisfied using Microgen's existing cash resources. The consideration of £9.7 million also includes 421,582 Microgen shares (valued at £2.0 million as at 30 August 2017) which will be issued in August 2019. The founder, CEO and former majority shareholder of RevStream, Rajiv Chopra, will remain with the business.

RevStream has experienced a significant increase in demand for its products and services in 2017. RevStream's on-going recurring revenue base is currently £2.9 million, an increase of 58% since 31 December 2016, with a number of further opportunities well progressed. RevStream's revenue in the year ended 31 December 2016 was £2.7 million; this is expected to more than double in 2017. RevStream reported a loss before tax in 2016 of £0.8 million. The gross assets at 31 December 2016 were £0.9 million. The acquisition of RevStream is anticipated to be earnings enhancing in 2018.

 

Contacts

Philip Wood, Chief Financial Officer 020-7496-8100

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGUGDIIBXBGRB
Date   Source Headline
5th Oct 201111:39 amRNSApplication for Block Listing
30th Sep 20114:13 pmRNSTotal Voting Rights
27th Sep 20115:27 pmRNSBlock Listing Return
8th Sep 20114:24 pmRNSHolding(s) in Company
7th Sep 20113:15 pmRNSDirector/PDMR Shareholding
5th Sep 20113:29 pmRNSHolding(s) in Company
5th Sep 20111:50 pmRNSHolding(s) in Company
31st Aug 20114:53 pmRNSTotal Voting Rights
31st Aug 20119:25 amRNSHolding(s) in Company
31st Aug 20118:33 amRNSDirectorship in Another PLC
31st Aug 20117:00 amRNSDirectorate Change
15th Aug 20111:21 pmRNSDirector/PDMR Shareholding
21st Jul 20117:00 amRNSInterim Results
7th Jul 20117:00 amRNSTrading Update
1st Jul 20119:00 amRNSBlocklisting Interim Review
30th Jun 20113:07 pmRNSTotal Voting Rights
24th Jun 20112:17 pmRNSHolding(s) in Company
23rd Jun 201111:45 amRNSHolding(s) in Company
21st Jun 20114:44 pmRNSHolding(s) in Company
24th May 201110:00 amRNSDirector Declaration
4th May 20119:43 amRNSHolding(s) in Company
19th Apr 20119:34 amRNSAGM Statement
19th Apr 20117:00 amRNSInterim Management Statement
31st Mar 20119:08 amRNSTotal Voting Rights
30th Mar 201112:25 pmRNSDirector/PDMR Shareholding
25th Mar 201110:10 amRNSBlock Listing Return
24th Mar 201112:22 pmRNSAnnual Information Update
2nd Mar 201110:11 amRNSHolding(s) in Company
28th Feb 201110:15 amRNSTotal Voting Rights
25th Feb 201111:53 amRNSDirector/PDMR Shareholding
24th Feb 20117:00 amRNSFinal Results
16th Feb 20113:18 pmRNSNotice of Results
3rd Feb 20115:00 pmRNSHolding(s) in Company
3rd Feb 20114:58 pmRNSHolding(s) in Company
28th Jan 201112:59 pmRNSHolding(s) in Company
17th Jan 20114:18 pmRNSDirector Declaration
14th Jan 20114:18 pmRNSHolding(s) in Company
10th Jan 20117:00 amRNSPre-close Trading Update
7th Jan 201111:49 amRNSBlocklisting Return
7th Jan 201111:48 amRNSBlocklisting Return
4th Jan 201110:10 amRNSTotal Voting Rights
4th Nov 20107:00 amRNSDirector/PDMR Shareholding
3rd Nov 20103:40 pmRNSHolding(s) in Company
29th Oct 201010:00 amRNSTotal Voting Rights
26th Oct 20107:00 amRNSInterim Management Statement
26th Oct 20107:00 amRNSInterim Management Statement
30th Sep 20107:00 amRNSTotal Voting Rights
29th Sep 20108:05 amRNSDirector/PDMR Shareholding
27th Sep 20107:01 amRNSBlocklisting Interim Review
23rd Sep 201010:59 amRNSApplication for Blocklisting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.